Texas Capital Bancshares’s AstraZeneca AZN Stock Holding History

Texas Capital Bancshares’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$84.1K	Sell	548 -1,462	-73%	-$221K	0.03%	93
2025 Q2	$281K	Sell	2,010 -75	-4%	-$10.5K	0.1%	67
2025 Q1	$306K	Hold	2,085	–	–	0.13%	61
2024 Q4	$273K	Buy	+2,085	New	+$292K	0.11%	65
2015 Q4	–	Sell	-4,135	Closed	-$263K	–	46
2015 Q3	$263K	Buy	4,135 +10	+0.2%	+$658	0.22%	69
2015 Q2	$263K	Buy	+4,125	New	+$282K	0.18%	92

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Texas Capital Bancshares's AZN Position: Q3 2025 in Review

Texas Capital Bancshares reduced its AstraZeneca (AZN) stake by 73% in Q3 2025, selling an estimated $221K and leaving 548 shares worth $84.1K. The position accounts for 0.03% of the portfolio, ranked #93.

Texas Capital Bancshares first reported a position in AZN in Q2 2015 and has held it in 6 quarters since. The position peaked at $306K in Q1 2025. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

Texas Capital Bancshares held 548 shares of AstraZeneca worth $84.1K as of Q3 2025.
Texas Capital Bancshares sold 1,462 AstraZeneca shares in Q3 2025, an estimated $221K.
AstraZeneca made up 0.03% of Texas Capital Bancshares's portfolio in Q3 2025, its #93 holding.
Texas Capital Bancshares first reported a position in AstraZeneca in Q2 2015 and has held it in 6 quarters since.
Texas Capital Bancshares's AstraZeneca position peaked at $306K in Q1 2025.
1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Texas Capital Bancshares's 13F filing for Q3 2025, filed 13 Nov 2025.